A conotoxin and an antagonist of α3β4 subunit-containing nAChRs
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

α-Conotoxin AuIB (trifluoroacetate salt)

Item No. 33795

Technical Information
Formal Name
cyclic (2→8), (3→15)-bis(disulfide), glycyl-L-cysteinyl-L-cysteinyl-L-seryl-L-tyrosyl-L-prolyl-L-prolyl-L-cysteinyl-L-phenylalanyl-L-alanyl-L-threonyl-L-asparaginyl-L-prolyl-L-α-aspartyl-L-cysteinamide, trifluoroacetate salt
Synonyms
  • GCCSYPPCFATNPDC
Molecular Formula
C65H89N17O21S4 • XCF3COOH
Formula Weight
Purity
≥95%
A solid
Water: 5 mg/ml
SMILES
O=C1[C@@]2([H])N(CCC2)C([C@@H](NC([C@@H](NC([C@@]3([H])NC([C@H](CSSC[C@@H](C(N[C@H](C(N[C@H](C(N[C@@](C(N[C@H](C(N4[C@](CCC4)([H])C(N[C@H](C(N[C@@H](CSSC3)C(N)=O)=O)CC(O)=O)=O)=O)CC(N)=O)=O)([H])[C@H](O)C)=O)C)=O)CC5=CC=CC=C5)=O)NC([C@@]6([H])N1CCC6)=O)NC(CN)=O)=O)=O)CO)=O)CC7=CC=C(C=C7)O)=O.OC(C(F)(F)F)=O
InChi Code
InChI=1S/C65H89N17O21S4.C2HF3O2/c1-31-53(91)79-51(32(2)84)62(100)74-39(23-48(67)86)64(102)80-18-6-11-45(80)60(98)72-37(24-50(88)89)55(93)76-41(52(68)90)27-104-106-29-43-59(97)75-40(26-83)56(94)73-38(22-34-14-16-35(85)17-15-34)63(101)82-20-8-13-47(82)65(103)81-19-7-12-46(81)61(99)78-44(30-107-105-28-42(57(95)77-43)70-49(87)25-66)58(96)71-36(54(92)69-31)21-33-9-4-3-5-10-33;3-2(4,5)1(6)7/h3-5,9-10,14-17,31-32,36-47,51,83-85H,6-8,11-13,18-30,66H2,1-2H3,(H2,67,86)(H2,68,90)(H,69,92)(H,70,87)(H,71,96)(H,72,98)(H,73,94)(H,74,100)(H,75,97)(H,76,93)(H,77,95)(H,78,99)(H,79,91)(H,88,89);(H,6,7)/t31-,32+,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,51-;/m0./s1
InChi Key
PHHCMNCPUIOVFH-UWWWOWFQSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Environmental Toxicology Resource Center

    Explore additional resources to study natural toxins, pollutants including PFAS and 6-PPD-Q, and their biological effects.

    ENVIRONMENTAL TOXICOLOGY TOOLS & SERVICES
    Product Description

    α-Conotoxin AuIB is a conotoxin that has been found in C. aulicus and has receptor antagonist and analgesic activity.1 It is a peptide antagonist of α3β4 subunit-containing nicotinic acetylcholine receptors (nAChRs; IC50 = 0.75 µM). It is greater than 100-fold selective for α3β4 subunit-containing nAChRs over those containing α2β2, α2β4, α3β2, α4β2, α4β4, or α1β1γδ subunits but does inhibit homomeric α7 nAChRs by 34% at 3 µM. Intrathecal administration of α-conotoxin AuIB (0.2 and 2 nmol/animal) reduces mechanical allodynia in a rat model of neuropathic pain induced by partial sciatic nerve ligation.2 It also reverses somatic signs of withdrawal in a mouse model of morphine withdrawal when administered intracerebroventricularly at doses of 1.75 and 3.5 pmol/animal.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Luo, S., Kulak, J.M., Cartier, G.E., et alα-Conotoxin AuIB selectively blocks α3 β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J. Neurosci. 18(21), 8571-8579 (1998).

    2. Napier, I.A., Klimis, H., Rycroft, B.K., et alIntrathecal α-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic pain. Neuropharmacology 62(7), 2202-2207 (2012).

    3. Muldoon, P.P., Jackson, K.J., Perez, E., et alThe α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies. Br. J. Pharmacol. 171(16), 3845-3857 (2014).